Table 3.
Change in Predicted %fPSA Mean (95% CI) |
p Value* | ||
---|---|---|---|
Age (per 5-yr increase) | −0.3 | (−0.5, −0.05) | 0.021 |
Race/ethnicity: | 0.048 | ||
NonHispanic white | 0 | (reference) | |
NonHispanic black | −0.4 | (−1.8, 0.9) | |
Mexican-American | −3.2 | (−4.8, −1.7) | |
Other | −1.3 | (−4.4, 1.7) | |
Smoking status: | 0.015 | ||
Current smoker | −1.2 | (−2.8, 0.4) | |
Former smoker | 1.2 | (−0.1, 2.5) | |
Never smoker | 0 | (reference) | |
BMI (per 5 kg/m2 increase) | 0.0 | (−0.6, 0.5) | 0.926 |
Diabetes: | 0.003 | ||
No | 0 | (reference) | |
Yes | 3.8 | (1.4, 6.2) | |
BPH: | 0.145 | ||
No | 0 | (reference) | |
Yes | −1.4 | (−3.4, 0.5) | |
Statin use: | 0.812 | ||
No | 0 | (reference) | |
Yes | −0.2 | (−1.6, 1.2) | |
NSAID use:† | 0.287 | ||
No | 0 | (reference) | |
Yes | 1.2 | (−1.0, 3.4) | |
Thiazide diuretic use: | 0.151 | ||
No | 0 | (reference) | |
Yes | 1.5 | (−0.6, 3.7) | |
C-reactive protein‡ | Nonlinear (nonlinear) | <0.001 |
All variables included in the model are shown in the table.
Based on the F-statistic with Satterthwaite correction for the degrees of freedom from the simultaneous test that all coefficients for a given variable are equal to 0.
Prescription only.
Increasing C-reactive protein was associated with a decrease in %fPSA for levels up to 0.7 mg/dl. Above this level there was no relationship between C-reactive protein and %fPSA.